Advertisement
YOU ARE HERE: LAT HomeCollections

Genetic Engineered Vaccine OKd

July 23, 1986|United Press International

WASHINGTON — The government today approved the sale of the first commercial vaccine produced by genetic engineering technology, a drug to prevent hepatitis B without raising "unwarranted fear" about AIDS contamination.

An anti-hepatitis vaccine has been available since 1982, but it is produced from blood plasma donated by hepatitis carriers who often are at high risk for AIDS as well. The new vaccine is made by yeast cells tricked into making a safe hepatitis virus component.

Advertisement
Los Angeles Times Articles
|
|
|